{
  "Covaxin_continents": "Africa, Asia, Europe, and South America",
  "Covaxin_country_count": "30",
  "Sinovac_continents": "Africa, Asia, Europe, North America, and South America",
  "Sinovac_country_count": "63",
  "owid_RNA_count": "2",
  "owid_RNA_countries": "168",
  "owid_RNA_map": "https://github.com/greenelab/covid19-review/raw/4213a836c8f00ca3061b0d6968e88c509592b843/owiddata/maps/RNA.png",
  "owid_VLP_count": "1",
  "owid_VLP_countries": "1",
  "owid_VLP_map": "https://github.com/greenelab/covid19-review/raw/4213a836c8f00ca3061b0d6968e88c509592b843/owiddata/maps/VLP.png",
  "owid_commit_date": "2022-08-16T07:05:45Z",
  "owid_commit_date_pretty": "August 16, 2022",
  "owid_commit_sha": "19ce9079401686da0f139e16f41aeb90e1506e39",
  "owid_doses_bargraph": "https://github.com/greenelab/covid19-review/raw/4213a836c8f00ca3061b0d6968e88c509592b843/OWID_dosesByContinent.png",
  "owid_doses_scatterplot": "https://github.com/greenelab/covid19-review/raw/4213a836c8f00ca3061b0d6968e88c509592b843/OWID_doseTypebyGDP.png",
  "owid_inactivated_count": "10",
  "owid_inactivated_countries": "116",
  "owid_inactivated_map": "https://github.com/greenelab/covid19-review/raw/4213a836c8f00ca3061b0d6968e88c509592b843/owiddata/maps/inactivated.png",
  "owid_most_recent_date": "August 15, 2022",
  "owid_non_replicating_viral_vector_count": "5",
  "owid_non_replicating_viral_vector_countries": "202",
  "owid_non_replicating_viral_vector_map": "https://github.com/greenelab/covid19-review/raw/4213a836c8f00ca3061b0d6968e88c509592b843/owiddata/maps/non_replicating_viral_vector.png",
  "owid_plasmid_vectored_count": "0",
  "owid_plasmid_vectored_countries": "0",
  "owid_protein_subunit_count": "10",
  "owid_protein_subunit_countries": "41",
  "owid_protein_subunit_map": "https://github.com/greenelab/covid19-review/raw/4213a836c8f00ca3061b0d6968e88c509592b843/owiddata/maps/protein_subunit.png",
  "owid_total_countries": "223",
  "owid_vaccine_counts": "29",
  "owid_worldwide_daily_rate": "745.0 per million",
  "owid_worldwide_date": "August 9, 2022",
  "owid_worldwide_total_vaccinations": "12.0 billion",
  "viper_approved_DNA": "| Vaccine                                      | Company                     | Platform                     |\n|:---------------------------------------------|:----------------------------|:-----------------------------|\n| Convidecia                                   | CanSino                     | non replicating viral vector |\n| Gam-COVID-Vac                                | Gamaleya                    | non replicating viral vector |\n| Sputnik Light                                | Gamaleya                    | non replicating viral vector |\n| Sputnik V                                    | Gamaleya                    | non replicating viral vector |\n| Ad26.COV2.S                                  | Janssen (Johnson & Johnson) | non replicating viral vector |\n| Vaxzevria                                    | Oxford/AstraZeneca          | non replicating viral vector |\n| Covishield (Oxford/ AstraZeneca formulation) | Serum Institute of India    | non replicating viral vector |\n| ZyCoV-D                                      | Zydus Cadila                | plasmid vectored             |",
  "viper_approved_RNA": "| Vaccine                       | Company                            |\n|:------------------------------|:-----------------------------------|\n| GEMCOVAC-19                   | Gennova Biopharmaceuticals Limited |\n| mRNA-1273.214                 | Moderna                            |\n| Spikevax                      | Moderna                            |\n| Comirnaty                     | Pfizer/BioNTech                    |\n| TAK-919 (Moderna formulation) | Takeda                             |",
  "viper_approved_subunit": "| Vaccine                                   | Company                                                    | Platform        |\n|:------------------------------------------|:-----------------------------------------------------------|:----------------|\n| Zifivax                                   | Anhui Zhifei Longcom                                       | protein subunit |\n| Noora vaccine                             | Bagheiat-allah University of Medical Sciences              | protein subunit |\n| Corbevax                                  | Biological E Limited                                       | protein subunit |\n| Abdala                                    | Center for Genetic Engineering and Biotechnology (CIGB)    | protein subunit |\n| Soberana 02                               | Instituto Finlay de Vacunas Cuba                           | protein subunit |\n| Soberana Plus                             | Instituto Finlay de Vacunas Cuba                           | protein subunit |\n| Covifenz                                  | Medicago                                                   | VLP             |\n| MVC-COV1901                               | Medigen                                                    | protein subunit |\n| Recombinant SARS-CoV-2 Vaccine (CHO Cell) | National Vaccine and Serum Institute                       | protein subunit |\n| Nuvaxovid                                 | Novavax                                                    | protein subunit |\n| Razi Cov Pars                             | Razi Vaccine and Serum Research Institute                  | protein subunit |\n| COVOVAX (Novavax formulation)             | Serum Institute of India                                   | protein subunit |\n| SKYCovione                                | SK Bioscience Co Ltd                                       | protein subunit |\n| TAK-019 (Novavax formulation)             | Takeda                                                     | protein subunit |\n| SpikoGen                                  | Vaxine/CinnaGen Co.                                        | protein subunit |\n| Aurora-CoV                                | Vector State Research Center of Virology and Biotechnology | protein subunit |\n| EpiVacCorona                              | Vector State Research Center of Virology and Biotechnology | protein subunit |",
  "viper_approved_whole_virus": "| Vaccine                  | Company                                                   |\n|:-------------------------|:----------------------------------------------------------|\n| Covaxin                  | Bharat Biotech                                            |\n| KoviVac                  | Chumakov Center                                           |\n| Turkovac                 | Health Institutes of Turkey                               |\n| FAKHRAVAC (MIVAC)        | Organization of Defensive Innovation and Research         |\n| QazVac                   | Research Institute for Biological Safety Problems (RIBSP) |\n| KCONVAC                  | Shenzhen Kangtai Biological Products Co                   |\n| COVIran Barekat          | Shifa Pharmed Industrial Co                               |\n| Covilo                   | Sinopharm (Beijing)                                       |\n| Inactivated (Vero Cells) | Sinopharm (Wuhan)                                         |\n| CoronaVac                | Sinovac                                                   |\n| VLA2001                  | Valneva                                                   |",
  "viper_date_pretty": "August 15, 2022",
  "viper_num_approved_DNA": 8,
  "viper_num_approved_RNA": 5,
  "viper_num_approved_subunit": 17,
  "viper_num_approved_whole_virus": 11,
  "viper_vaccine_counts": "41",
  "viper_vax_dev_Africa": "No approved vaccines have been developed in Africa [@url:https://covid19.trackvaccines.org].",
  "viper_vax_dev_Asia": "Vaccines have been developed in 6 countries in Asia, including China (Convidecia, CanSino; Covilo, Sinopharm (Beijing); CoronaVac, Sinovac; Inactivated (Vero Cells), Sinopharm (Wuhan); nan, nan; KCONVAC, Shenzhen Kangtai Biological Products Co; Zifivax, Anhui Zhifei Longcom), India (Covaxin, Bharat Biotech; Corbevax, Biological E Limited), Iran (COVIran Barekat, Shifa Pharmed Industrial Co; FAKHRAVAC (MIVAC), Organization of Defensive Innovation and Research; Razi Cov Pars, Razi Vaccine and Serum Research Institute), Kazakhstan (QazVac, Research Institute for Biological Safety Problems (RIBSP)), Taiwan (MVC-COV1901, Medigen), and Turkey (Turkovac, Health Institutes of Turkey).",
  "viper_vax_dev_Europe": "Vaccines have been developed in 4 countries in Europe, including the Netherlands (Ad26.COV2.S, Janssen (Johnson & Johnson)), United Kingdom (Vaxzevria, Oxford/AstraZeneca), Germany (Comirnaty, Pfizer/BioNTech), and Russia (Sputnik Light, Gamaleya; Sputnik V, Gamaleya; EpiVacCorona, Vector State Research Center of Virology and Biotechnology; KoviVac, Chumakov Center).",
  "viper_vax_dev_North_America": "Vaccines have been developed in 2 countries in North America, including the United States of America (mRNA-1273.214, Moderna; Comirnaty, Pfizer/BioNTech; Nuvaxovid, Novavax), and Cuba (Abdala, Center for Genetic Engineering and Biotechnology (CIGB); Soberana Plus, Instituto Finlay de Vacunas Cuba; Soberana 02, Instituto Finlay de Vacunas Cuba).",
  "viper_vax_dev_Oceania": "The only approved vaccine developed in Oceania is SpikoGen, which was developed by Vaxine/CinnaGen Co. in Australia [@url:https://covid19.trackvaccines.org].",
  "viper_vax_dev_South_America": "No approved vaccines have been developed in South America [@url:https://covid19.trackvaccines.org]."
}